ArticleEndocrine2024

Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA.

Udhayvir Singh Grewal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.